| Trial Identifier: | D9604C00001 |
| Sponsor: | AstraZeneca |
| NCTID:: | NCT05926349 |
| Start Date: | August 2024 |
| Primary Completion Date: | January 2027 |
| Study Completion Date: | September 2027 |
For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.
No documents have been posted yet.